Novavax Net Borrowings from 2010 to 2024

NVAX Stock  USD 8.62  0.13  1.49%   
Novavax Net Borrowings yearly trend continues to be fairly stable with very little volatility. Net Borrowings is likely to outpace its year average in 2024. Net Borrowings is the difference between the amount of new debt Novavax has taken on and the amount of debt it has paid off during a given period. View All Fundamentals
 
Net Borrowings  
First Reported
2012-03-31
Previous Quarter
-453 K
Current Value
1.8 M
Quarterly Volatility
60.9 M
 
Yuan Drop
 
Covid
Check Novavax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novavax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.3 M, Interest Expense of 15.1 M or Selling General Administrative of 499.1 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0066 or Days Sales Outstanding of 82.31. Novavax financial statements analysis is a perfect complement when working with Novavax Valuation or Volatility modules.
  
Check out the analysis of Novavax Correlation against competitors.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Latest Novavax's Net Borrowings Growth Pattern

Below is the plot of the Net Borrowings of Novavax over the last few years. It is the difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period. Novavax's Net Borrowings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novavax's overall financial position and show how it may be relating to other accounts over time.
Net Borrowings10 Years Trend
Very volatile
   Net Borrowings   
       Timeline  

Novavax Net Borrowings Regression Statistics

Arithmetic Mean8,585,832
Geometric Mean6,092,725
Coefficient Of Variation1,243
Mean Deviation68,228,553
Median(80,000)
Standard Deviation106,704,869
Sample Variance11385.9T
Range441.7M
R-Value(0)
Mean Square Error12261.7T
R-Squared0.00000206
Significance1.00
Slope(34,272)
Total Sum of Squares159403T

Novavax Net Borrowings History

202477.2 M
202373.5 M
202281.7 M
2021-127.9 M
2018-96.1 M
2017-37 K
2016313.7 M

About Novavax Financial Statements

Novavax investors use historical fundamental indicators, such as Novavax's Net Borrowings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novavax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Borrowings73.5 M77.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.